About
Firefly Neuroscience specializes in AI-powered brain assessments aimed at neurological disorders. The company focuses on enhancing clinical insights through artificial intelligence and data analytics, which supports greater precision in neurological care. Their flagship product, Brain Network Analytics (BNA™), is an FDA-cleared technology that analyzes EEG data using advanced AI and machine learning algorithms. BNA™ compares this data against a proprietary database of over 17,000 individuals, including healthy volunteers and patients with various cognitive disorders. This analysis helps detect subtle neurological deviations, facilitating early diagnosis and personalized care plans. Firefly Neuroscience serves clinicians and healthcare providers who seek comprehensive neurological assessments, as well as CNS drug developers and pharmaceutical companies interested in leveraging their biomarker technology. The company aims to improve patient outcomes through precision medicine by integrating neuroscience, AI, and big data into neurological diagnostics and therapeutic development.
Technologies
Keywords
Company Information
-
Employees 13
-
Founded 2006
-
Annual Revenue $108000
-
Total Funding $43540754
Location
1100 Military Rd, Buffalo, New York, United States, 14217-2514